Image may be NSFW.
Clik here to view.
Two class action lawsuits filed against Novocure (NSDQ:NVCR) and some of its directors and executives in January were dismissed after the court established that it lacked personal jurisdiction over any of the defendants.
In mid-January, Joseph Donahue, Stephen Rosen and Susan Rosen filed two putative class action suits in a New Hampshire court against Novocure, its directors, some of its officers and the underwriters of its October 2015 initial public offering. The plaintiffs alleged that the company misstated or omitted information in Novocure’s initial public offering materials, violating federal securities law.
Get the full story at our sister site, Drug Delivery Business News.
The post Court dismisses class action suits against Novocure appeared first on MassDevice.
